Try it
Pharmacology · Drug interactions
Sample itemA kidney transplant patient on azathioprine is started on allopurinol for gout and develops pancytopenia. What explains this?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Xanthine oxidase inhibition prevents inactivation of 6-mercaptopurine
Azathioprine is converted to 6-mercaptopurine, which xanthine oxidase inactivates to thiouric acid. Allopurinol blocks this enzyme, raising active thiopurine levels and causing marrow toxicity, so the azathioprine dose must be greatly reduced.
Option by option
A. Allopurinol induces hepatic enzymes producing toxic metabolites
Allopurinol inhibits rather than induces enzymes.
B. Allopurinol displaces azathioprine from plasma proteins
Protein-binding displacement is not the mechanism of this interaction.
C. Xanthine oxidase inhibition prevents inactivation of 6-mercaptopurine (correct)
Blocking xanthine oxidase leaves more active thiopurine, causing marrow toxicity.
D. Allopurinol blocks the conversion of azathioprine to its active form
Activation of azathioprine is not impaired; active drug accumulates instead.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Drug interactionsA woman using an oral contraceptive pill is started on rifampicin for tuberculosis. Why…
- Drug interactionsA patient on sertraline for depression is started on linezolid for a resistant staphyloc…
- Drug interactionsWhat is enzyme induction likely to do to a substrate drug concentration?
- Drug interactionsWhat is enzyme inhibition likely to do to a substrate drug concentration?